Syntec Optics receives nearly $4M in life sciences purchase orders
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
Syntec Optics (Nasdaq: OPTX) Secures over $4M in New BioMed Orders Across Diversified Life Sciences Platforms
June 22, 2026 8:53 AM EDTROCHESTER, NEW YORK, June 22, 2026 (GLOBE NEWSWIRE) -- Syntec Optics (Nasdaq: OPTX), a leading provider of mission-critical technologies for vibrant end-markets - defense tech, space tech, and biomed tech today announced it received nearly $4 million in U.S. life sciences purchase orders.Â
As the quality of healthcare in the U.S. advances, Syntec Optics is playing a pivotal role in providing the high-precision optical products required for existing and next-generation technologies.Â
Building on the previously announced $4.6 million in orders for laser blood analysis optics used in nearly every leading clinic and hospital,... More
